Page 154 - Glucose Monitoring Devices

155
References

[22] Lachin JM, et al. Effect of glycemic exposure on the risk of microvascular complica-
tions in the diabetes control and complications trial–revisited. Diabetes 2008;57:
995e1001.
[23] Kilpatrick ES, Rigby AS, Atkin SL. Mean blood glucose compared with HbA1c in the
prediction of cardiovascular disease in patients with type 1 diabetes. Diabetologia
2008;51:365e71.
[24] Forbes A, Murrells T, Mulnier H, Sinclair AJ. Mean HbA1c, HbA1c variability, and
mortality in people with diabetes aged 70 years and older: a retrospective cohort
study. The Lancet Diabetes and Endocrinology 2018;6:476e86.
[25] Tang X, et al. Glycemic variability evaluated by continuous glucose monitoring system
is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled
HbA1c. Clinica Chimica Acta 2016;461:146e50.
[26] Schutt M, et al. Is the frequency of self-monitoring of blood glucose related to long-
term metabolic control? Multicenter analysis including 24,500 patients from 191 cen-
ters in Germany and Austria. Experimental and Clinical Endocrinology and Diabetes
2006;114:384e8.
[27] Miller KM, et al. Evidence of a strong association between frequency of self-
monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic reg-
istry participants. Diabetes Care 2013;36:2009e14.
[28] Karter AJ, et al. Self-monitoring of blood glucose levels and glycemic control: the
Northern California Kaiser Permanente Diabetes registry. The American Journal of
Medicine 2001;111:1e9.
[29] Evans JM, et al. Frequency of blood glucose monitoring in relation to glycaemic
control: observational study with diabetes database. BMJ 1999;319:83e6.
[30] National clinical guideline centre (UK). 2015.
[31] American Diabetes Association. 6. Glycemic targets: standards of medical care in dia-
betes-2018. Diabetes Care 2018;41:S55e64.
[32] Heinemann L. Finger pricking and pain: a never ending story. Journal of Diabetes
Science and Technology 2008;2:919e21.
[33] Mostrom P, Ahlen E, Imberg H, Hansson PO, Lind M. Adherence of self-monitoring of
blood glucose in persons with type 1 diabetes in Sweden. BMJ Open Diabetes
Research and Care 2017;5:e000342.
[34] Schmidt MI, Hadji-Georgopoulos A, Rendell M, Margolis S, Kowarski A. The dawn
phenomenon, an early morning glucose rise: implications for diabetic intraday blood
glucose variation. Diabetes Care 1981;4:579e85.
[35] Schmidt MI, Lin QX, Gwynne JT, Jacobs S. Fasting early morning rise in peripheral
insulin: evidence of the dawn phenomenon in nondiabetes. Diabetes Care 1984;7.
[36] Campbell IW. The somogyi phenomenon. A short review. Acta Diabetologia Latina
1976;13:68e73.
[37] Porcellati F, Lucidi P, Bolli GB, Fanelli CG. Thirty years of research on the dawn phe-
nomenon: lessons to optimize blood glucose control in diabetes. Diabetes Care 2013;
36:3860e2.
[38] Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of
hypoglycaemia in adults with type 1 diabetes. Diabetic Medicine 2008;25:501e4.
[39] Colberg SR, et al. Physical activity/exercise and diabetes: a position statement of the
American diabetes association. Diabetes Care 2016;39:2065e79.